Article
Pluripotent stem cell replacement approaches to treat type 1 diabetes.
Current opinion in pharmacology - 1 Dec 2018
Pellegrini Silvia, Piemonti Lorenzo, Sordi Valeria
Abstract excerpt
Stem cells represent a potential candidate for β cell replacement in type 1 diabetes. Pluripotent stem cells are able to differentiate in vitro into functional insulin producing cells, that can restore normoglycemia in diabetic mice. Clinical trials with embryonic stem cell-derived pancreatic progenitors are ongoing. Besides, induced pluripotent stem cells offer the chance of personalized cell therapy. So far,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
